G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California , Los Angeles, California.
Inflammatory Bowel Disease Research Center, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California , Los Angeles, California.
Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G140-G157. doi: 10.1152/ajpgi.00288.2017. Epub 2018 Mar 22.
Peripheral factors likely play a role in at least a subset of irritable bowel syndrome (IBS) patients. Few studies have investigated mucosal gene expression using an unbiased approach. Here, we performed mucosal gene profiling in a sex-balanced sample to identify relevant signaling pathways and gene networks and compare with publicly available profiling data from additional cohorts. Twenty Rome III+ IBS patients [10 IBS with constipation (IBS-C), 10 IBS with diarrhea (IBS-D), 5 men/women each), and 10 age-/sex-matched healthy controls (HCs)] underwent sigmoidoscopy with biopsy for gene microarray analysis, including differential expression, weighted gene coexpression network analysis (WGCNA), gene set enrichment analysis, and comparison with publicly available data. Expression levels of 67 genes were validated in an expanded cohort, including the above samples and 18 additional participants (6 each of IBS-C, IBS-D, HCs) using NanoString nCounter technology. There were 1,270 differentially expressed genes (FDR < 0.05) in IBS-C vs. HCs but none in IBS or IBS-D vs. HCs. WGNCA analysis identified activation of the cAMP/protein kinase A signaling pathway. Nine of 67 genes were validated by the NanoString nCounter technology (FDR < 0.05) in the expanded sample. Comparison with publicly available microarray data from the Mayo Clinic and University of Nottingham supports the reproducibility of 17 genes from the microarray analysis and three of nine genes validated by nCounter in IBS-C vs. HCs. This study supports the involvement of peripheral mechanisms in IBS-C, particularly pathways mediating neuronal signaling. NEW & NOTEWORTHY Peripheral factors play a role in the pathophysiology of irritable bowel syndrome (IBS), which, to date, has been mostly evident in IBS with diarrhea. Here, we show that sigmoid colon mucosal gene expression profiles differentiate IBS with constipation from healthy controls. These profiling data and analysis of additional cohorts also support the concept that peripheral neuronal pathways contribute to IBS pathophysiology.
外周因素可能至少在一部分肠易激综合征(IBS)患者中起作用。很少有研究使用无偏方法研究粘膜基因表达。在这里,我们对性别平衡的样本进行了粘膜基因谱分析,以确定相关的信号通路和基因网络,并与其他队列中可公开获得的分析数据进行比较。20 名罗马 III+IBS 患者[10 名 IBS 伴便秘(IBS-C),10 名 IBS 伴腹泻(IBS-D),男女各 5 名]和 10 名年龄/性别匹配的健康对照者(HCs)接受了乙状结肠镜检查和活检,用于基因微阵列分析,包括差异表达、加权基因共表达网络分析(WGCNA)、基因集富集分析,并与可公开获得的数据进行比较。使用 NanoString nCounter 技术在扩展队列中验证了 67 个基因的表达水平,包括上述样本和另外 18 个参与者(IBS-C 各 6 个,IBS-D 各 6 个,HCs 各 6 个)。IBS-C 与 HCs 相比,有 1270 个差异表达基因(FDR<0.05),而 IBS 或 IBS-D 与 HCs 相比则没有。WGNCA 分析发现 cAMP/蛋白激酶 A 信号通路的激活。在扩展样本中,NanoString nCounter 技术验证了 67 个基因中的 9 个(FDR<0.05)。与梅奥诊所和诺丁汉大学可公开获得的微阵列数据进行比较支持了微阵列分析中 17 个基因和 nCounter 验证的 9 个基因中 3 个在 IBS-C 与 HCs 之间的可重复性。本研究支持外周机制在 IBS-C 中的作用,特别是在介导神经元信号的途径中。新意和亮点外周因素在肠易激综合征(IBS)的发病机制中起作用,迄今为止,这在腹泻型 IBS 中最为明显。在这里,我们表明,乙状结肠粘膜基因表达谱可区分 IBS-C 与健康对照者。这些分析数据和对其他队列的分析还支持外周神经元途径有助于 IBS 发病机制的概念。